Both in Pharmaceuticals
SIGA Technologies vs Keros Therapeutics
Over the past year SIGA returned −64.0% and KROS returned −29.3%; their daily moves had a correlation of 0.18.
SIGA −64.0% KROS −29.3%Growth of $1, one year, split-adjusted
| Metric | SIGA | KROS |
|---|---|---|
| Price | $2.95 | $10.76 |
| Market cap | $212.0M | $213.3M |
| Today | −2.96% | −2.54% |
| 1 month | −12.7% | −5.3% |
| 6 months | −36.3% | −8.1% |
| Year to date | −51.7% | −47.2% |
| 1 year | −64.5% | −28.4% |
| Revenue growth (YoY) | −49.5% | −100.0% |
| Gross margin | 57.2% | — |
| Net margin | 30.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | 14.2× |
| Net cash | $117.6M | $257.6M |
| Dividend yield | 20.34% | — |
| Volatility (60d) | 42.5% | 44.1% |
| Short % of float | 8.8% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).